Skip to main content
OpenTrials

Clinical trial condition

Prostate Adenocarcinoma

Explore clinical trials studying Prostate Adenocarcinoma. Study availability and eligibility vary by location and protocol.

194 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Prostate Adenocarcinoma trial results

Completed

131-I-TM-601 Study in Adults With Solid Tumors

NCT00379132

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +41 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Northwestern University, The Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Chicago Chicago, Illinois, United States
  • Tufts - New England Medical Center Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

PSMA PET Imaging of Recurrent Prostate Cancer

NCT03204123

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Consent only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent only ) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Consent only) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

NCT04513717

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
Locations
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Arizona Center for Cancer Care - Gilbert Gilbert, Arizona, United States
  • Arizona Center for Cancer Care-Peoria Peoria, Arizona, United States
View all 602 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

NCT05053152

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • Marin General Hospital Greenbrae, California, United States
View all 245 locations
View Trial Details
Active, Not Recruiting

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

NCT05050084

Conditions
Prostate Adenocarcinoma
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Arizona Center for Cancer Care - Gilbert Gilbert, Arizona, United States
  • Arizona Center for Cancer Care-Peoria Peoria, Arizona, United States
View all 576 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

NCT04134260

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
  • Kaiser Permanente-Baldwin Park Baldwin Park, California, United States
View all 350 locations
View Trial Details

Related conditions